Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Makena Active Ingredient Compounding Ban Would Be Limited To Preterm Birth Prevention
Oct 17 2024
•
By
Sue Sutter
The FDA is proposing to prohibit compounding of Makena's active ingredient for preventing preterm birth.
(Shutterstock)
More from US Advisory Committees
More from Geography